• Company
    • About Us
    • Vision & Mission
    • History
    • Management Board
    • Supervisory Board
    • Contact Us
  • Pipeline
    • What are Biosimilars?
    • Biosimilar Pipeline
    • FYB201
    • FYB202
    • FYB203
    • FYB206
  • Sustainability
    • Responsibility
    • Strategy and Areas of Action
      • Environment
      • Social
        • Diversity & Equality
        • Safety & Health
        • Training & Skills Development
        • Value Chain
        • Patients
      • Governance
        • Corporate Culture
        • Compliance
        • Animal Welfare
    • ESG Management
    • Reports and downloads
  • Investor Relations
    • About Formycon
      • Equity Story
      • Company Presentation
      • FAQ
    • Uplisting
    • Formycon Shares
      • Share Chart
      • Shareholder Structure
      • Analyst Coverage
    • Financial Calendar
    • Financial Reports
    • Annual General Meeting
      • Annual General Meeting 2024
      • Annual General Meeting 2023
      • Annual General Meeting 2022
    • Statutory Publications
      • Ad-Hoc Releases
      • Voting Rights Notifications
      • Directors Dealings
    • Governance
    • Contact
  • Newsroom
    • Press Releases
    • Blog
    • Social Media
    • News Archive
  • Careers
    • Why Formycon
    • Your Benefits
    • Job Offers
EN
Loading...

Centered Gallery Full-Width

Sidebar Custom One

Centered Slides Full-Width

Centered Custom Two

Sidebar Gallery

Centered Gallery

Company
About Us Vision & Mission History Management Board Supervisory Board
News
Press Releases
Pipeline
What are Biosimilars? Biosimilar Pipeline FYB201 FYB202 FYB203 FYB206
Career
Why Formycon Your Benefits Job Offers
Investors
About Formycon Uplisting Formycon Shares Financial Calendar Annual General Meeting Publications Governance
Contact
Location & Approach
Social
Twitter XING LinkedIn
Member of Bio Deutschland Member of Medicines for Europe Member of UN Global Compact
Formycon AG
The Biosimilar Experts

© Formycon AG

Legal Notice Data Protection